Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Glitazones

Glitazones

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
      • Alpha-Glucosidase Inhibitors (21)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (17)
      • Gliptins (63)
      • Glitazones (72)
      • GLP-1 (31)
      • Incretin Enhancers/Mimetics (46)
      • Insulin (128)
      • Meglitinides (32)
      • Metformin (94)
      • SGLT2 Inhibitors (56)
      • Sulfonylureas (80)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
46 - 60 of 72 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: changes in treatment of polycystic ovary syndrome (PCOS) May 2014
Article: emphasis on improving care in diabetes patients April 2014
Commentary: FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions January 2014
Article: help improve medication adherence December 2013
Patient Education: Tips for Sticking With Your Meds November 2013
Patient Education: How to Handle Low Blood Sugar August 2013
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) August 2013
Article: more emphasis on preventing and treating dangerously LOW blood sugar in patients with diabetes August 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
Commentary: Sick Day Management of Diabetes March 2013
Article: how to manage diabetes during an acute illness March 2013
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
Commentary: Glitazones and the Risk of Bladder Cancer October 2012
Article: MORE controversy about using pioglitazone (Actos, etc) for type 2 diabetes October 2012
Article: more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN July 2012
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved